SYQUANT CAPITAL SAS

Position in OCS — Oculis Holding AG

CIK 1766392 PARIS, I0

Position in OCS

as of Jun 30, 2026 · filed Jul 9, 2026 Compact

Position Value

$5,201,250

-$724,783 QoQ

Shares Held

375,000

+68.3% QoQ

Ownership

0.621%

of shares outstanding

% of Portfolio

1.28%

of 13F equity value

Holder Rank

of 3 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Jun 30, 2026

SYQUANT CAPITAL SAS holds $13,916,670 across 3 Biotechnology names. OCS ranks #2 (37.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABVX	Abivax S.A.	39,500	$5,263,770
2	OCS	Oculis Holding AG This page	375,000	$5,201,250
3	IVA	Inventiva S.A.	913,135	$3,451,650

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$5,201,250	375,000	+68.3%	Shares	Sole	2026-07-09
2026-03-31	$5,926,033	222,867	+15.6%	Shares	Sole	2026-04-10
2025-12-31	$3,848,658	192,722	—	Shares	Sole	2026-01-13
No filing history on record for this holder in this stock.